PerkinElmer is the global leader in prenatal, neonatal and mass spectrometry-based screening, providing the platforms of choice in many parts of the world. We have been in partnership with PerkinElmer since the founding of HVD Life Sciences in 1994. Through that partnership we developed the Egyptian Newborn Screening Laboratory in Cairo, the largest and one of the most technologically advanced neonatal screening units in the world. Whether your needs are large or small, we have the expertise to help you choose the right technology from among the industry-leading PerkinElmer clinical screening platforms.
Prenatal Screening Systems
Through PerkinElmer, we offer three alternative platforms that provide comprehensive methods for assessing the well-being of both mothers-to-be and fetuses. Each platform delivers the high analytical sensitivity and premium performance you require for clinical applications.
Find out more…
Neonatal Screening Systems
The PerkinElmer neonatal screening platform is used to detect congenital diseases that are treatable only when identified during the first days of life. We supply all of the PerkinElmer instruments, kits, reagents and software that you need to establish a superior neonatal screening program.
Find out more…
Clinical Mass Spectrometry Systems
PerkinElmer has integrated their expertise in both mass spectrometry and clinical diagnostics to play a pioneering role in introducing tandem mass spectrometry (MSMS) for clinical applications. We bring that expertise to you with our PerkinElmer MSMS profiling reagents, kits and informatics solutions.
Find out more...